Terms: = Kidney tumors AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169
74 results:
1. Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas.
Lu X; Vano YA; Su X; Helleux A; Lindner V; Mouawad R; Spano JP; Rouprêt M; Compérat E; Verkarre V; Sun CM; Bennamoun M; Lang H; Barthelemy P; Cheng W; Xu L; Davidson I; Yan F; Fridman WH; Sautes-Fridman C; Oudard S; Malouf GG
Cell Rep Med; 2023 Nov; 4(11):101287. PubMed ID: 37967556
[TBL] [Abstract] [Full Text] [Related]
2. Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (ezh2).
Xu X; Chen J; Wang G; Zhang X; Li Q; Zhou X; Guo F; Li M
Bioorg Med Chem Lett; 2024 Jan; 97():129558. PubMed ID: 37956762
[TBL] [Abstract] [Full Text] [Related]
3. Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma.
Saggese P; Pandey A; Alcaraz M; Fung E; Hall A; Yanagawa J; Rodriguez EF; Grogan TR; Giurato G; Nassa G; Salvati A; Shirihai OS; Weisz A; Dubinett SM; Scafoglio C
Cancer Res; 2024 Jan; 84(2):305-327. PubMed ID: 37934116
[TBL] [Abstract] [Full Text] [Related]
4. RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and ezh2 stability.
Wu Y; Xu Z; Chen X; Fu G; Tian J; Jin B
Cancer Med; 2023 Oct; 12(19):19889-19903. PubMed ID: 37747077
[TBL] [Abstract] [Full Text] [Related]
5. Long noncoding RNA UFC1 acts as an oncogene via stimulating ezh2-induced inhibition of APC expression in renal cell carcinoma.
Wang J; Liu G
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):152-156. PubMed ID: 37329532
[TBL] [Abstract] [Full Text] [Related]
6. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma.
Liu Y; Cheng X; Xi P; Zhang Z; Sun T; Gong B
BMC Urol; 2023 Apr; 23(1):54. PubMed ID: 37004005
[TBL] [Abstract] [Full Text] [Related]
7. Epigenetic reactivation of PEG3 by ezh2 inhibitors suppresses renal clear cell carcinoma progress.
Qiu T; Ding Y; Qin J; Ren D; Xie M; Qian Q; Wang Y; Ma L; Jing A; Yang J; Ma S; Wang X; Wang W; Ji J; Li G
Cell Signal; 2023 Jul; 107():110662. PubMed ID: 37001595
[TBL] [Abstract] [Full Text] [Related]
8. FAK-mediated phosphorylation at Y464 regulates p85β nuclear translocation to promote tumorigenesis of ccRCC by repressing RB1 expression.
Zhang Y; He B; Zhang D; Zhang Y; Chen C; Zhang W; Yang S; Yao M; Cui G; Gu J; Wang T; Lin Z; Fan Y; Xiong Z; Hao Y
Cell Rep; 2023 Mar; 42(3):112188. PubMed ID: 36857183
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of ezh2 exerts antitumorigenic effects in renal cell carcinoma via LATS1.
Hong SH; Hwang HJ; Son DH; Kim ES; Park SY; Yoon YE
FEBS Open Bio; 2023 Apr; 13(4):724-735. PubMed ID: 36808829
[TBL] [Abstract] [Full Text] [Related]
10. The role of histone methylation in renal cell cancer: an update.
Hou Y; Yuan Y; Li Y; Wang L; Hu J; Liu X
Mol Biol Rep; 2023 Mar; 50(3):2735-2742. PubMed ID: 36575323
[TBL] [Abstract] [Full Text] [Related]
11. DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma.
Zhu Y; Liu X; Wang Y; Pan Y; Han X; Peng B; Zhang X; Niu S; Wang H; Ye Q; Gu Y; Gao S
Cell Death Dis; 2022 May; 13(5):456. PubMed ID: 35562342
[TBL] [Abstract] [Full Text] [Related]
12. Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma.
Han W; Fan B; Huang Y; Wang X; Zhang Z; Gu G; Liu Z
BMC Nephrol; 2022 May; 23(1):172. PubMed ID: 35513791
[TBL] [Abstract] [Full Text] [Related]
13. PRAME protein expression in DICER1-related tumours.
Thorner PS; Chong AS; Nadaf J; Benlimame N; Marrano P; Chami R; Fu L; Foulkes WD
J Pathol Clin Res; 2022 May; 8(3):294-304. PubMed ID: 35297207
[TBL] [Abstract] [Full Text] [Related]
14. Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer.
Baker SC; Mason AS; Slip RG; Skinner KT; Macdonald A; Masood O; Harris RS; Fenton TR; Periyasamy M; Ali S; Southgate J
Oncogene; 2022 Apr; 41(15):2139-2151. PubMed ID: 35194151
[TBL] [Abstract] [Full Text] [Related]
15. Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration.
Xing Q; Jiaochen Luan ; Shouyong Liu ; Limin Ma ; Wang Y
Bosn J Basic Med Sci; 2022 Jun; 22(3):435-452. PubMed ID: 34420511
[TBL] [Abstract] [Full Text] [Related]
16. miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting ezh2.
Dong Y; Gao Y; Xie T; Liu H; Zhan X; Xu Y
Biomed Res Int; 2021; 2021():9950749. PubMed ID: 34307682
[TBL] [Abstract] [Full Text] [Related]
17. Mutant CDKN2A regulates P16/p14 expression by alternative splicing in renal cell carcinoma metastasis.
Sun Q; Chen S; Hou Y; Wen X; Teng X; Zhang H; Lai C; Lai M
Pathol Res Pract; 2021 Jul; 223():153453. PubMed ID: 34022680
[TBL] [Abstract] [Full Text] [Related]
18. Development and Clinical Validation of a Seven-Gene Prognostic Signature Based on Multiple Machine Learning Algorithms in kidney Cancer.
Tian M; Wang T; Wang P
Cell Transplant; 2021; 30():963689720969176. PubMed ID: 33626918
[TBL] [Abstract] [Full Text] [Related]
19. ZMYND8 preferentially binds phosphorylated ezh2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor-activated cancer.
Tang B; Sun R; Wang D; Sheng H; Wei T; Wang L; Zhang J; Ho TH; Yang L; Wei Q; Huang H
Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593912
[TBL] [Abstract] [Full Text] [Related]
20. Integral Analysis of the RNA Binding Protein-associated Prognostic Model for Renal Cell Carcinoma.
Qin X; Liu Z; Yan K; Fang Z; Fan Y
Int J Med Sci; 2021; 18(4):953-963. PubMed ID: 33456353
[TBL] [Abstract] [Full Text] [Related]
[Next]
